The early results of the induction therapy comparison (alemtuzumab versus basiliximab) were presented at the World Transplant Congress in San Francisco on 28 July 2014. The slides that were presented can be downloaded here.
The results were also published in The Lancet and the paper can be accessed here.
A press release that accompanied the presentation and publication can be downloaded here.
The first results of the maintenance therapy comparison (sirolimus versus tacrolimus) were presented at the European Society of Transplantation meeting in Barcelona on 25th September 2017. The slides that were presented can be downloaded here
We are very grateful to the participants who took part in the trial.